SE8604839L - Tiazol/4,5c/kinoliner - Google Patents

Tiazol/4,5c/kinoliner

Info

Publication number
SE8604839L
SE8604839L SE8604839A SE8604839A SE8604839L SE 8604839 L SE8604839 L SE 8604839L SE 8604839 A SE8604839 A SE 8604839A SE 8604839 A SE8604839 A SE 8604839A SE 8604839 L SE8604839 L SE 8604839L
Authority
SE
Sweden
Prior art keywords
general formula
phenyl
hydrogen
compounds
lower alkyl
Prior art date
Application number
SE8604839A
Other languages
English (en)
Swedish (sv)
Other versions
SE8604839D0 (sv
Inventor
J Knoll
E Berenyi
K Budai
B Knoll
Z Forts
J Timbr
G Zsila
I Niklya
L Petocz
A Mandi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of SE8604839D0 publication Critical patent/SE8604839D0/xx
Publication of SE8604839L publication Critical patent/SE8604839L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8604839A 1985-11-12 1986-11-12 Tiazol/4,5c/kinoliner SE8604839L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU854304A HU197019B (en) 1985-11-12 1985-11-12 Process for producing thiqzolo (4,5-c) quinoline derivatives and pharmaceuticals comprising same

Publications (2)

Publication Number Publication Date
SE8604839D0 SE8604839D0 (sv) 1986-11-12
SE8604839L true SE8604839L (sv) 1987-05-13

Family

ID=10967593

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604839A SE8604839L (sv) 1985-11-12 1986-11-12 Tiazol/4,5c/kinoliner

Country Status (24)

Country Link
US (1) US4904669A (pl)
JP (1) JPS62161792A (pl)
CN (1) CN86107754A (pl)
AU (1) AU592384B2 (pl)
BE (1) BE905719A (pl)
BG (1) BG46156A3 (pl)
CH (1) CH670829A5 (pl)
DD (1) DD254202A5 (pl)
DE (1) DE3638563A1 (pl)
DK (1) DK539786A (pl)
ES (1) ES2002543A6 (pl)
FI (1) FI864611A (pl)
FR (1) FR2603588A1 (pl)
GB (1) GB2184117B (pl)
HU (1) HU197019B (pl)
IL (1) IL80611A0 (pl)
IT (1) IT1213379B (pl)
NL (1) NL8602878A (pl)
NO (1) NO864518L (pl)
PL (1) PL148186B1 (pl)
SE (1) SE8604839L (pl)
SU (1) SU1544190A3 (pl)
YU (1) YU192186A (pl)
ZA (1) ZA868583B (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU199423B (en) * 1987-04-24 1990-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 3-amino-4-/ethylthio/-quinoline and pharmaceutical compositions comprising such compounds
US6110929A (en) 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
US6677347B2 (en) * 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
EP1617845A4 (en) * 2003-04-28 2006-09-20 3M Innovative Properties Co COMPOSITIONS AND METHODS FOR INDUCING OPOID RECEPTORS
TW200510412A (en) * 2003-08-12 2005-03-16 3M Innovative Properties Co Oxime substituted imidazo-containing compounds
US7897597B2 (en) * 2003-08-27 2011-03-01 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
JP2007504269A (ja) * 2003-09-05 2007-03-01 スリーエム イノベイティブ プロパティズ カンパニー Ｃｄ５＋ｂ細胞リンパ腫の治療方法
US7544697B2 (en) * 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
US20090075980A1 (en) * 2003-10-03 2009-03-19 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and Analogs Thereof
WO2005032484A2 (en) * 2003-10-03 2005-04-14 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
EP1682544A4 (en) * 2003-11-14 2009-05-06 3M Innovative Properties Co HYDROXYLAMINE SUBSTITUTED IMIDAZO RING COMPOUNDS
US7897767B2 (en) 2003-11-14 2011-03-01 3M Innovative Properties Company Oxime substituted imidazoquinolines
AR046781A1 (es) * 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
WO2005066170A1 (en) * 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066169A2 (en) * 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
TW200612932A (en) * 2004-03-24 2006-05-01 3M Innovative Properties Co Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) * 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7897609B2 (en) * 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009826A1 (en) * 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006065280A2 (en) * 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US20070259881A1 (en) * 2004-06-18 2007-11-08 Dellaria Joseph F Jr Substituted Imidazo Ring Systems and Methods
US20090270443A1 (en) * 2004-09-02 2009-10-29 Doris Stoermer 1-amino imidazo-containing compounds and methods
US20110070575A1 (en) * 2004-12-08 2011-03-24 Coley Pharmaceutical Group, Inc. Immunomodulatory Compositions, Combinations and Methods
ES2392647T3 (es) * 2004-12-30 2012-12-12 3M Innovative Properties Company Compuestos tetracíclicos quirales que inducen la biosíntesis de interferón
CA2594674C (en) 2004-12-30 2016-05-17 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2006210392A1 (en) * 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
AU2006338521A1 (en) * 2005-02-09 2007-10-11 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods
AU2006213746A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2006107853A2 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
US7906506B2 (en) * 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
EP3870581B1 (en) 2018-10-23 2023-06-14 Basf Se Tricyclic pesticidal compounds
CN115427408A (zh) 2020-04-14 2022-12-02 巴斯夫欧洲公司 杀害虫的三环化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024207A (en) * 1978-05-26 1980-01-09 Lepetit Spa New tricyclic ortho-fused heterocyclic compounds
HU196308B (en) * 1985-11-12 1988-11-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions containing 2-methyl-thiazolo/4,5-c/quinoline as active component

Also Published As

Publication number Publication date
DK539786D0 (da) 1986-11-12
ES2002543A6 (es) 1988-08-16
IT1213379B (it) 1989-12-20
IL80611A0 (en) 1987-02-27
US4904669A (en) 1990-02-27
PL262346A1 (en) 1988-03-03
DD254202A5 (de) 1988-02-17
AU592384B2 (en) 1990-01-11
SU1544190A3 (ru) 1990-02-15
YU192186A (en) 1988-10-31
FI864611A (fi) 1987-05-13
GB8627043D0 (en) 1986-12-10
NO864518L (no) 1987-05-13
GB2184117A (en) 1987-06-17
ZA868583B (en) 1987-08-26
CH670829A5 (pl) 1989-07-14
CN86107754A (zh) 1987-08-05
BG46156A3 (en) 1989-10-16
HU197019B (en) 1989-02-28
FR2603588A1 (fr) 1988-03-11
GB2184117B (en) 1989-10-11
FI864611A0 (fi) 1986-11-12
IT8622312A0 (it) 1986-11-12
BE905719A (fr) 1987-05-07
DK539786A (da) 1987-05-13
NL8602878A (nl) 1987-06-01
SE8604839D0 (sv) 1986-11-12
NO864518D0 (no) 1986-11-12
HUT44260A (en) 1988-02-29
JPS62161792A (ja) 1987-07-17
AU6508986A (en) 1987-05-14
PL148186B1 (en) 1989-09-30
DE3638563A1 (de) 1987-06-25

Similar Documents

Publication Publication Date Title
SE8604839L (sv) Tiazol/4,5c/kinoliner
ATE49763T1 (de) 1h-imidazo(4,5c)chinoline und 1h-imidazo(4,5c)chinolin-4-amine.
PT87700A (pt) Process for the preparation of a new pyrazolopyridine compound
MY100574A (en) 5-substituted-2-cyclopropyl-6, 8-difluoroquinoline derivatives and processes for preparation thereof
PT79819A (en) Process to prepare dihydropiridazinone derivatives its salts and pharmaceutical compositions and intermediate compounds there with
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
HUP9802393A2 (hu) Benzotiazolonszármazékok, alkalmazásuk, az ezeket tartalmazó gyógyszerkészítmények, eljárás a vegyületek előállítására és intermedierjeik
KR900011770A (ko) 신규 벤조 [1,8] 나프티리딘 유도체, 그 제조방법 및 상기 유도체를 함유하는 조성물
ES2056835T3 (es) Derivados de pirido(2,3-d)pirimidina.
IL75987A0 (en) 1,6-naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
ES8801637A1 (es) Un procedimiento para la preparacion de benzimidazoles.
GR70356B (pl)
FR2626279B1 (fr) Nouveaux derives de l'indolo(3,2,1-de)(1,4)-oxazino(2,3,4-ij)(1,5) naphthyridine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
PT84172A (pt) Process for the preparation of quinoleine derivatives
IL59358A (en) Hydroxytetrahydro(phenoxymethyl)-imidazothiazole and thiazolopyrimidine derivatives,their preparation and pharmaceutical compositions containing them
ATE67197T1 (de) Thiadiazinon-derivate.
IL97611A (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
ES2002111A6 (es) Un procedimiento para preparar pirimido-(2,1-b)-benzotiazoles
ES8200661A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina
SE8405332D0 (sv) 2h-azeto(2,1-a)-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
TH4681A (th) กรรมวิธีสำหรับเตรียมสารไธแอโซโล (4, 5-c) ควิโนลีน
TH4681EX (th) กรรมวิธีสำหรับเตรียมสารไธแอโซโล (4, 5-c) ควิโนลีน

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8604839-4

Effective date: 19901115

Format of ref document f/p: F